Cargando…
Flexible Initial Dosing of Atorvastatin Based Upon Initial Low-Density Lipoprotein Cholesterol Levels in Type 2 Diabetic Patients
BACKGROUND/AIMS: We used flexible starting doses and early titration of atorvastatin to determine the rate of achievement of a low-density lipoprotein cholesterol (LDL-C) target for hyperlipidemic patients with type 2 diabetes mellitus. METHODS: This study was a multicenter, open-label, prospective...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686951/ https://www.ncbi.nlm.nih.gov/pubmed/18363276 http://dx.doi.org/10.3904/kjim.2008.23.1.22 |
Ejemplares similares
-
Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
por: Najafipour, Mostafa, et al.
Publicado: (2018) -
Effects of patient‐tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low‐density lipoprotein cholesterol in patients with type 2 diabetes
por: Son, Jang Won, et al.
Publicado: (2013) -
Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin
por: Ong, Kwok Leung, et al.
Publicado: (2018) -
Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
por: Bays, Harold E
Publicado: (2014) -
Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study
por: Lim, Yu-Cheol, et al.
Publicado: (2023)